- Order:
- Duration: 5:00
- Published: 03 May 2009
- Uploaded: 10 Aug 2011
- Author: prehn100
Company logo | |
---|
Gambro is a global medical technology company that manufactures products for Dialysis treatment. The company is a global leader in developing, manufacturing and supplying products and therapies for Kidney and Liver Dialysis, Myeloma Kidney Therapy, and other extracorporeal therapies for Chronic and Acute patients. Gambro was founded in Lund, Sweden in 1964 by Holger Crafoord and has approx. 8,000 employees, production facilities in 9 countries, and sales in more than 100 countries.
The development of single-use artificial kidneys began in Lund, Sweden and mass production started in 1967 with the “Ad-modum-Alwall” dialyzer. The company adopted the name Gambro, which is the abbreviation of the original Swedish company name: “Gamla Brogatans Sjukvårdsaffär Aktiebolag". Roughly translated, this means “The Old Bridge Street Medical Supplies Company". The company’s first plant outside Sweden was built in Hechingen, Germany in the 1970s. In 1983, Gambro became listed on the Stockholm Stock Exchange. On April 3, 2006, Indap AB, joint-owned by Swedish investment companies EQT and Investor AB, announced a public cash offer to the shareholders of Gambro to acquire all outstanding shares in the company. The new ownership structure of Gambro became effective in June 2006. In recent decades, Gambro’s range of products and therapies has grown - through the introduction of new products, as well as several acquisitions, such as Hospal in 1987, COBE in 1990 and the latest addition of CHF Solutions Inc. in 2010. CHF Solutions designs and manufactures therapies and products for treating fluid overload by means of ultrafiltration.
Category:Companies established in 1964 Category:Health care companies of Sweden
This text is licensed under the Creative Commons CC-BY-SA License. This text was originally published on Wikipedia and was developed by the Wikipedia community.